461 related articles for article (PubMed ID: 28245859)
1. Californium-252 neutron brachytherapy combined with external pelvic radiotherapy plus concurrent chemotherapy for cervical cancer: a retrospective clinical study.
Qian S; Ye L; Tian YH; Wang LG; Huang ZP; Li F; Hou B; Song N; Chen J; Liu Y; Liu X; Zhou T
Chin J Cancer; 2017 Feb; 36(1):24. PubMed ID: 28245859
[TBL] [Abstract][Full Text] [Related]
2. Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer.
Zhang M; Xu HD; Pan SD; Lin S; Yue JH; Liu JR
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):966-71. PubMed ID: 22138462
[TBL] [Abstract][Full Text] [Related]
3. A feasibility study of 252Cf neutron brachytherapy, cisplatin + 5-FU chemo-adjuvant and accelerated hyperfractionated radiotherapy for advanced cervical cancer.
Maruyama Y; Bowen MG; Van Nagell JR; Gallion HH; DePriest P; Wierzbicki J
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):529-34. PubMed ID: 8005811
[TBL] [Abstract][Full Text] [Related]
4. Hypoxic versus normoxic external-beam irradiation of cervical carcinoma combined with californium-252 neutron brachytherapy. Comparative treatment results of a 5-year randomized study.
Tacev T; Vacek A; Ptácková B; Strnad V
Strahlenther Onkol; 2005 May; 181(5):273-84. PubMed ID: 15900423
[TBL] [Abstract][Full Text] [Related]
5. Californium-252 brachytherapy combined with external-beam radiotherapy for cervical cancer: long-term treatment results.
Lei X; Qian CY; Qing Y; Zhao KW; Yang ZZ; Dai N; Zhong ZY; Tang C; Li Z; Gu XQ; Zhou Q; Feng Y; Xiong YL; Shan JL; Wang D
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1264-70. PubMed ID: 21435797
[TBL] [Abstract][Full Text] [Related]
6. Postoperative external beam irradiation with and without brachytherapy in pelvic node-positive IB1-IIA2 cervical cancer patients: a retrospective clinical study.
Li L; Kou X; Feng X; Zhang M; Chao H; Wang L
Radiat Oncol; 2015 Sep; 10():189. PubMed ID: 26377326
[TBL] [Abstract][Full Text] [Related]
7. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
Chen CC; Wang L; Lin JC; Jan JS
J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
[TBL] [Abstract][Full Text] [Related]
8. Californium-252 neutron brachytherapy combined with external beam radiotherapy for esophageal cancer: long-term treatment results.
Liu H; Wang Q; Wan X; Jia X; Liu B; Wang CK
Brachytherapy; 2014; 13(5):514-21. PubMed ID: 24818780
[TBL] [Abstract][Full Text] [Related]
9. Treatment of stage IIIB cervical cancer with Californium-252 fast-neutron brachytherapy and external photon therapy.
Gallion HH; Maruyama Y; van Nagell JR; Donaldson ES; Rowley KC; Yoneda J; Beach JL; Powell DE; Kryscio RJ
Cancer; 1987 May; 59(10):1709-12. PubMed ID: 3828944
[TBL] [Abstract][Full Text] [Related]
10. Distant metastasis in patients with cervical cancer after primary radiotherapy with or without chemotherapy and image guided adaptive brachytherapy.
Schmid MP; Franckena M; Kirchheiner K; Sturdza A; Georg P; Dörr W; Pötter R
Gynecol Oncol; 2014 May; 133(2):256-62. PubMed ID: 24517875
[TBL] [Abstract][Full Text] [Related]
11. Phase II clinical trial using californium 252 fast neutron brachytherapy, external pelvic radiation, and extrafascial hysterectomy in the treatment of bulky, barrel-shaped stage IB cervical cancer.
van Nagell JR; Maruyama Y; Donaldson ES; Hanson MB; Gallion HH; Yoneda J; Powell DE; Kryscio RJ; Beach JL
Cancer; 1986 May; 57(10):1918-22. PubMed ID: 3513939
[TBL] [Abstract][Full Text] [Related]
12. Long-term results for Stage IIIB cervical cancer patients receiving external beam radiotherapy combined with either HDR (252)Cf or HDR (60)Co intracavitary brachytherapy.
Ulinskas K; Janulionis E; Valuckas KP; Samerdokiene V; Atkocius V; Rivard MJ
Brachytherapy; 2016; 15(3):353-360. PubMed ID: 26996594
[TBL] [Abstract][Full Text] [Related]
13. Combined external and intracavitary irradiation in treatment of advanced cervical carcinomas: predictive factors for local tumor control and early recurrences.
Sorbe B; Bohr L; Karlsson L; Bermark B
Int J Oncol; 2010 Feb; 36(2):371-8. PubMed ID: 20043071
[TBL] [Abstract][Full Text] [Related]
14. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH
Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448
[TBL] [Abstract][Full Text] [Related]
15. A retrospective study of external beam radiation, neutron brachytherapy, and concurrent chemotherapy for patients with localized advanced carcinoma of the esophagus.
Ma K; Wang Q; Li T; Liu H; Liu B; Jia X; Li S; Lang J; Zhang M
Radiat Oncol; 2014 Dec; 9():294. PubMed ID: 25515326
[TBL] [Abstract][Full Text] [Related]
16. Concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer.
Toita T; Moromizato H; Ogawa K; Kakinohana Y; Maehama T; Kanazawa K; Murayama S
Gynecol Oncol; 2005 Mar; 96(3):665-70. PubMed ID: 15721409
[TBL] [Abstract][Full Text] [Related]
17. A review of californium-252 neutron brachytherapy for cervical cancer.
Maruyama Y; van Nagell JR; Yoneda J; Donaldson ES; Gallion HH; Powell D; Kryscio RJ
Cancer; 1991 Sep; 68(6):1189-97. PubMed ID: 1873769
[TBL] [Abstract][Full Text] [Related]
18. Combination of external beam radiotherapy and Californium (Cf)-252 neutron intracavity brachytherapy is more effective in control of cervical squamous cell carcinoma than that of cervical adenocarcinoma.
Xiong Y; Liu J; Chen S; Zhou Q; Xu W; Tang C; Chen Y; Yang M; Lei X
Med Oncol; 2015 Sep; 32(9):231. PubMed ID: 26271794
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of chemoradiotherapy in cervical cancer--the Western Australian experience.
Lim A; Sia S
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1431-8. PubMed ID: 21640504
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer: combined modality therapy.
Grigsby PW
Cancer J; 2001; 7 Suppl 1():S47-50. PubMed ID: 11504285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
